The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer (Q36468076)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

0 references

author name string

Bronchud MH

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Howell A

2

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Crowther D

3

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Hopwood P

4

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Souza L

5

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dexter TM

6

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

language of work or name

0 references

publication date

1 July 1989

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

60

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

121-125

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

High-dose doxorubicin: an exploration of the dose-response curve in human neoplasia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

A comparison of two doses of adriamycin in the primary chemotherapy of disseminated breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

Advanced breast cancer: high-dose chemotherapy and bone marrow autotransplants

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

The role of high-dose chemotherapy with autologous bone marrow transplantation in the treatment of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

Dose-response in the treatment of breast cancer: a critical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

Assessment of response to therapy in advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

Amputation and adriamycin in primary osteosarcoma: a 5-year report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

30 September 2017

A phase I-II study of intensive-dose adriamycin for advanced breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

28 June 2018

Quality of life in cancer trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247341

28 June 2018

Criteria associated with destruction of leukemia and solid tumor cells in animals

1 reference

https://pubmed.ncbi.nlm.nih.gov/2478178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin therapy for advanced ovarian carcinoma recurrent after chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2478178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose: a critical factor in cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2478178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2478178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response is alive and well

1 reference

https://pubmed.ncbi.nlm.nih.gov/2478178

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1989.234

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36468076&oldid=2198937604"